According to him, the small and mid-caps are expected to surge up to 20% over the upcoming 12 months ... Its strategic initiatives and growth drivers include private label development, technology and ...
The study of dielectric properties of biological materials, ranging from exosomes and cells to organoids and tissues, is a burgeoning field in biophysics and bioengineering. The primary challenge in ...
Cash, cash equivalents, and marketable securities of $360.1 million at Q3 2024 - CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical ...